Page 4 - Eyepoint Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

EYPT Stock Earnings: EyePoint Pharmaceuticals Misses EPS, Beats Revenue for Q1 2024

EYPT Stock Earnings: EyePoint Pharmaceuticals Misses EPS, Beats Revenue for Q1 2024
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

Eyepoint pharmaceuticalsEyepoint pharmaceuticals missesMarket newsStock adviceBeats revenue

EyePoint Pharmaceuticals (NASDAQ:EYPT) PT Lowered to $38 00

EyePoint Pharmaceuticals (NASDAQ:EYPT) PT Lowered to $38 00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Robertw bairdTower research capitalEyepoint pharmaceuticals tradingEyepoint pharmaceuticals incAnalyst recommendations for eyepoint pharmaceuticalsJpmorgan chase coInstitutional trading of eyepoint pharmaceuticalsEyepoint pharmaceuticalsToth financial advisory corpNews ratings for eyepoint pharmaceuticals dailySherbrooke park advisersChina universal asset management coInvestment advisersGet free reportCapital one financialPoint pharmaceuticals

Mizuho Trims EyePoint Pharmaceuticals (NASDAQ:EYPT) Target Price to $30 00

Mizuho Trims EyePoint Pharmaceuticals (NASDAQ:EYPT) Target Price to $30 00
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Analyst recommendations for eyepoint pharmaceuticalsJpmorgan chase coEyepoint pharmaceuticals trading downEyepoint pharmaceuticalsEyepoint pharmaceuticals incFirst turn managementJennison associatesInsider transactions at eyepoint pharmaceuticalsHermes incNews ratings for eyepoint pharmaceuticals dailyFranklin resources incGet free reportCapital one financialPoint pharmaceuticals trading downPoint pharmaceuticalsCormorant asset management

Research Analysts Price Target Changes for May 7th (ACM, ADCT, ADNT, ADUS, AL, ALB, ALG, ALNY, AMG, AMR)

Research Analysts Price Target Changes for May 7th (ACM, ADCT, ADNT, ADUS, AL, ALB, ALG, ALNY, AMG, AMR)
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Stifel nicolausRoth mkmRobertw bairdPiper sandlerCraig hallumLiberty latin americaHealth sciencesInternational flavors fragrancesResearch analystMontauk renewablesCanaccord genuity group incDeutsche bank aktiengesellschaftJefferies financial group incTruist financial coPennon groupCorvus pharmaceuticals

Phase 2 nonproliferative diabetic retinopathy trial misses primary endpoint

Phase 2 nonproliferative diabetic retinopathy trial misses primary endpoint
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Jays dukerEyepoint pharmaceuticalsDiabetic retinopathy severity scaleBreaking news